Mustgrow Biologics Corp
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home … Read more
Mustgrow Biologics Corp (MGROF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.108x
Based on the latest financial reports, Mustgrow Biologics Corp (MGROF) has a cash flow conversion efficiency ratio of -0.108x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-314.14K) by net assets ($2.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mustgrow Biologics Corp - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Mustgrow Biologics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mustgrow Biologics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mustgrow Biologics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UNITEKNO Co.Ltd
KQ:241690
|
-0.002x |
|
Malaysia Steel Works KL Bhd
KLSE:5098
|
0.065x |
|
Ledlink Optics
TWO:5230
|
0.045x |
|
Valbiotis SAS
PA:ALVAL
|
-0.333x |
|
INFOvine co. Ltd
KQ:115310
|
0.005x |
|
Louisa Professional Coffee Ltd
TWO:2758
|
0.151x |
|
Chiho Environmental Group Limited
STU:T4N
|
-0.017x |
|
B7X
F:B7X
|
-0.318x |
Annual Cash Flow Conversion Efficiency for Mustgrow Biologics Corp (2016–2024)
The table below shows the annual cash flow conversion efficiency of Mustgrow Biologics Corp from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.17 Million | $-3.58 Million | -1.649x | -3024.61% |
| 2023-12-31 | $5.58 Million | $-294.76K | -0.053x | +91.51% |
| 2022-12-31 | $5.24 Million | $-3.26 Million | -0.622x | -118.02% |
| 2021-12-31 | $8.46 Million | $-2.41 Million | -0.285x | +74.29% |
| 2020-12-31 | $2.32 Million | $-2.58 Million | -1.109x | -148.59% |
| 2019-12-31 | $3.03 Million | $-1.35 Million | -0.446x | -122.37% |
| 2018-12-31 | $-485.55K | $-968.35K | 1.994x | +219.95% |
| 2017-12-31 | $132.50K | $-220.29K | -1.663x | -1989.00% |
| 2016-12-31 | $-29.17K | $-2.57K | 0.088x | -- |